Topic

Chris Spivey is the editorial director of 

Articles

Researchers from the Telomere-to-Telomere Consortium have discovered new properties about junk DNA that could have wide-reaching implications.

The process of reshaping inevitably leads to fresh insights.

Change of roster does not change the goal line. We are all patients first.

The mission continues. Let science be the guide.

Vaccines define the path to putting pandemic restrictions and pain in the rear-view mirror.

Bio/pharmaceutical manufacturers have made a good first step toward global vaccination through pledging doses at no- to low-profit rates. 

Mike Hennessy, Sr., is the founder and chairman of MJH Life Sciences.

Innovation drives the development of emerging drug modalities. 

As face masks start to come off, bio/pharma’s COVID-19 battle goes on.

Smart, accurate, science-based messaging is needed to advance bio/pharma science.

Bio/pharma works hard today to change the calendar to tomorrow.